Literature DB >> 20607829

Epigenetic regulation of cancer growth by histone demethylases.

Soyoung Lim1, Eric Metzger, Roland Schüle, Jutta Kirfel, Reinhard Buettner.   

Abstract

Cancer is traditionally viewed as a primarily genetic disorder. However, it is now increasingly apparent that epigenetic abnormalities play a fundamental role in cancer development. Aberrant expression of histone-modifying enzymes has been implicated in the course of tumor initiation and progression. The discovery of a large number of histone demethylases suggests an important role for dynamic regulation of histone methylation in biological processes. The observation that overexpression, amplification or mutations of several histone demethylases have been found in many types of tumors, raise the possibility of using these enzymes as diagnostic tools as well as pave a way for the discovery of novel therapeutic targets and treatment modalities. Here, we review the current knowledge of the potential role of H3K4, H3K9 and H3K27 histone demethylases in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607829     DOI: 10.1002/ijc.25538

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  39 in total

Review 1.  Chromatin landscape: methylation beyond transcription.

Authors:  Joshua C Black; Johnathan R Whetstine
Journal:  Epigenetics       Date:  2011-01-01       Impact factor: 4.528

2.  MassSQUIRM: An assay for quantitative measurement of lysine demethylase activity.

Authors:  Lauren P Blair; Nathan L Avaritt; Rong Huang; Phillip A Cole; Sean D Taverna; Alan J Tackett
Journal:  Epigenetics       Date:  2011-04-01       Impact factor: 4.528

3.  Inhibition of histone demethylases by 4-carboxy-2,2'-bipyridyl compounds.

Authors:  Kai-Hsuan Chang; Oliver N F King; Anthony Tumber; Esther C Y Woon; Tom D Heightman; Michael A McDonough; Christopher J Schofield; Nathan R Rose
Journal:  ChemMedChem       Date:  2011-03-15       Impact factor: 3.466

4.  Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor.

Authors:  Pei-Ching Chang; Latricia D Fitzgerald; Datsun A Hsia; Yoshihiro Izumiya; Chun-Yi Wu; Wen-Ping Hsieh; Su-Fang Lin; Mel Campbell; Kit S Lam; Paul A Luciw; Clifford G Tepper; Hsing-Jien Kung
Journal:  J Virol       Date:  2011-01-12       Impact factor: 5.103

5.  Symmetry breaking and inter-clonal behavioural variability in a slime mould.

Authors:  David Vogel; Audrey Dussutour; Jean-Louis Deneubourg
Journal:  Biol Lett       Date:  2018-12-21       Impact factor: 3.703

6.  ERRα induces H3K9 demethylation by LSD1 to promote cell invasion.

Authors:  Julie Carnesecchi; Christelle Forcet; Ling Zhang; Violaine Tribollet; Bruno Barenton; Rafik Boudra; Catherine Cerutti; Isabelle M L Billas; Aurélien A Sérandour; Jason S Carroll; Claude Beaudoin; Jean-Marc Vanacker
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 7.  Epigenetic control of the tumor microenvironment.

Authors:  David L Marks; Rachel Lo Olson; Martin E Fernandez-Zapico
Journal:  Epigenomics       Date:  2016-10-04       Impact factor: 4.778

8.  Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients.

Authors:  Ze-Kun Zhao; Hai-Feng Yu; Dao-Rong Wang; Ping Dong; Lei Chen; Wen-Guang Wu; Wen-Jun Ding; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 9.  Oxidative stress and chromatin remodeling in chronic obstructive pulmonary disease and smoking-related diseases.

Authors:  Isaac K Sundar; Hongwei Yao; Irfan Rahman
Journal:  Antioxid Redox Signal       Date:  2012-11-06       Impact factor: 8.401

10.  MicroRNA-627 mediates the epigenetic mechanisms of vitamin D to suppress proliferation of human colorectal cancer cells and growth of xenograft tumors in mice.

Authors:  Sathish K R Padi; Qunshu Zhang; Youcef M Rustum; Carl Morrison; Bin Guo
Journal:  Gastroenterology       Date:  2013-04-22       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.